---
title: "RxSight Q2 FY26 net loss widens 2.6% to $12.1 million; revenue rises 0.3% to $33.7 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295018909.md"
description: "RxSight reported Q2 FY26 revenue of $33.74 million, up 0.3% YoY, driven by a $6.5 million license fee from an Alcon collaboration that offset a 19% drop in product sales. Net loss widened to $12.1 million, while operating loss narrowed to $13.77 million. Product gross margin fell to 71.2%. Aziz Mottiwala was named CEO effective July 20."
datetime: "2026-08-05T21:24:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295018909.md)
  - [en](https://longbridge.com/en/news/295018909.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295018909.md)
generator: "portal-rs"
---

# RxSight Q2 FY26 net loss widens 2.6% to $12.1 million; revenue rises 0.3% to $33.7 million

-   RxSight posted Q2 revenue of $33.74 million, up 0.3% year over year, as a $6.5 million license fee offset weaker product sales. \* Operating loss narrowed to $13.77 million; net loss widened to $12.1 million, while product gross margin fell 3.7 percentage points to 71.2%. \* Product sales slid 19% to $27.24 million on lower LDD and LAL unit volumes, with LDD revenue dropping to $1.34 million from fewer placements. \* LDDs sold fell to 11 from 40, while LALs sold eased to 24,917; the installed base rose to 1,166 at quarter-end. \* RxSight named Aziz Mottiwala CEO effective July 20, added him to the board, and signed a collaboration with Alcon that generated the $6.5 million license revenue. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RxSight Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-335153), on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [RXST.US](https://longbridge.com/en/quote/RXST.US.md)
- [ALC.US](https://longbridge.com/en/quote/ALC.US.md)

## Related News & Research

- [ALC: Record revenue, strong ARR growth, and strategic acquisition drive positive FY 2027 outlook](https://longbridge.com/en/news/296293743.md)
- [ALC: Strong sales growth offset by a major impairment charge led to sharply lower earnings](https://longbridge.com/en/news/295486138.md)
- [Mondelez declares Q3 2026 distribution of R$ 0.3 per unit, payable Oct. 20](https://longbridge.com/en/news/296392808.md)
- [Eye care company Alcon raises margin outlook, shares jump](https://longbridge.com/en/news/295501993.md)
- [ADP July group passenger traffic rises 0.3% to 36.6 million](https://longbridge.com/en/news/296135329.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**